Steven A Elms

Bio

Mr Elms joined Fund I in mid-2000, and currently serves as a Managing Partner. Previously, he was a Principal in the Life Sciences Investment Banking Group of Hambrecht & Quist. During his five years at H & Q, Mr Elms was involved in over 60 financing and M&A transactions, helping clients raise in excess of $3.3 billion in capital. Prior to H & Q, Mr Elms traded mortgage-backed securities at Donaldson, Lufkin & Jenrette. His previous healthcare sector experience includes over two years as a pharmaceutical sales representative for Marion Laboratories and two years as a consultant for The Wilkerson Group. Mr Elms currently serves as a director of ADMA Biologics Inc, Advion BioSciences Inc, Ambit Biosciences Corporation, Archemica Cooperatief UA, CeNeRx BioPharma Inc, LensAR Inc, MAP Pharmaceuticals Inc, Next Wave Pharmaceuticals Inc. and Tria Beauty Inc. Previously he served as a director of Avera Pharmaceuticals Inc, Bioenvision Inc, and Novazyme Pharmaceuticals Inc, and was Chairman of the Board of Adams Respiratory Therapeutics Inc. and Oculex Pharmaceuticals Inc. Mr Elms received his MBA from the Kellogg Graduate School of Management at Northwestern University, and his BA in Human Biology from Stanford University.